Loading institutional data...
Loading institutional data...
Held by 277 of 6,047 reporting institutions (93th percentile) — extremely crowded.
Data as of Q2 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 22 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-06-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EHC | $12.3B | 22.4× | — | 2.1× | 10.5% | — | 9.5% | 23.2% | 23.2% | — | 568 |
| DVA | $11.6B | 18.5× | 4.0× | 0.8× | 6.5% | — | 5.5% | -115% | -115% | -0.3× | 616 |
| UHS | $10.6B | 7.8× | 5.9× | 0.6× | 9.7% | — | 8.6% | 20.5% | 12.4% | 1.8× | 578 |
| ENSG | $10.1B | 29.7× | 18.4× | 2.0× | 18.7% | 20.5% | 6.8% | 15.4% | 14.5% | -0.7× | 522 |
| CAI | $8.3B | — | 117.1× | 10.3× | 97.0% | — | -8.4% | -11.8% | -7.1% | -6.2× | 244 |
| PACS | $7.0B | 36.4× | — | 1.3× | 29.3% | — | 3.6% | 20.2% | 16.0% | — | 234 |
| HIMS | $6.9B | 58.3× | 41.9× | 3.0× | 59.0% | 73.8% | 5.5% | 23.7% | 23.7% | -1.4× | 507 |
| CHE | $6.5B | 27.3× | 16.1× | 2.6× | 4.1% | 32.5% | 10.5% | 27.1% | 27.1% | -0.2× | 516 |
| RDNT | $5.6B | — | 27.8× | 2.8× | 11.5% | — | -0.9% | -1.7% | -0.9% | 1.5× | 318 |
| SHC | $5.2B | 67.4× | 17.9× | 4.5× | 5.7% | 55.5% | 6.7% | 12.9% | 2.8% | 4.6× | 310 |
| CON | $4.8B | 28.9× | 16.4× | 2.2× | 13.9% | — | 7.7% | 42.3% | 8.5% | 3.9× | 277 |
| LFST | $4.7B | — | 71.7× | 3.3× | 13.9% | — | 0.7% | 0.6% | 0.5% | 0.5× | 285 |
| OPCH | $4.7B | 24.5× | 13.8× | 0.8× | 13.0% | 19.3% | 3.7% | 15.7% | 8.3% | 2.3× | 363 |
| BLLN | $4.5B | — | 175.3× | 14.6× | 100.0% | 68.3% | 2.4% | 1.6% | 1.4% | -19.1× | 153 |
| NHC | $3.6B | 30.2× | 20.6× | 2.4× | 16.1% | — | 7.9% | 11.2% | 10.8% | -0.3× | 242 |
| VCYT | $3.5B | 52.6× | 39.2× | 6.7× | 16.0% | 70.1% | 12.8% | 5.1% | 5.1% | -4.6× | 350 |
| PRVA | $2.8B | 120.3× | 51.8× | 1.3× | 22.3% | — | 1.1% | 3.1% | 3.1% | -10.9× | 290 |
| AVAH | $2.7B | 11.6× | 14.1× | 1.1× | 20.2% | 33.3% | 9.2% | 116% | 15.1% | 4.2× | 207 |
| BKD | $2.4B | — | 16.8× | 0.8× | 2.2% | 26.2% | -8.2% | 587% | -6.2% | 10.5× | 287 |
| MD | $2.2B | 13.7× | 7.8× | 1.1× | -4.9% | — | 8.6% | 19.1% | 19.1% | -1.6× | 288 |
| ADUS | $2.1B | 21.9× | 14.1× | 1.5× | 23.2% | 32.5% | 6.7% | 8.8% | 8.0% | 0.3× | 287 |
| PGNY | $2.1B | 42.1× | 22.1× | 1.6× | 10.4% | 23.6% | 4.5% | 11.3% | 11.3% | -1.2× | 302 |
| WGS | $1.9B | — | — | 4.5× | 40.0% | 69.7% | -4.9% | -6.8% | -5.8% | — | 219 |
Peers = companies sharing CON's sector (Services-Specialty Outpatient Facilities, NEC) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 16% of free cash flow, leaving room to grow it and fund buybacks. Last year: $32.1M dividends + $22.4M buybacks = $54.5M returned on $197.1M FCF.
2 consecutive years of dividend increases · 301%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 4 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 8%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 4 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-14
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 42% against ROIC 8% — 34% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 49.8% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| SG&A | 8.7 | 8.3 | 8.2 | 9.4 |
| Operating Income | 15.0 | 15.6 | 16.0 | 15.4 |
| Income Tax | 3.1 | 3.1 | 3.1 | 2.4 |
| Net Income | 9.7 | 9.8 | 8.8 | 7.7 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CON: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $37.46 today, the market must believe free cash flow compounds 10.1%/yr for a decade (off $192.3M on the 3-yr avg basis).
On the basis ($187.8M) the requirement is 10.4%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 10.1% is more optimistic than its 3-yr track record.
Default is 8.2% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.13B shares (market data) · net debt $1.49B
mean -2.6% · volatility σ 25% · implied rate exceeded in 1/3 yrs
Central path = implied 10.1%/yr growth; shaded band = ±1σ (25%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~6.9% on $1.57B of debt.
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-10-14
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $2.16B 100.0% | $1.90B 100.0% | $1.84B 100.0% | $1.72B 100.0% |
| Selling, General & Admin | $203.3M 9.4% | $156.3M 8.2% | $152.0M 8.3% | $150.0M 8.7% |
| Total Operating Expenses | $1.83B 84.6% | $1.60B 84.0% | $1.55B 84.4% | $1.47B 85.0% |
| Operating Income | $334.0M 15.4% | $304.8M 16.0% | $287.6M 15.6% | $258.5M 15.0% |
| Interest Expense | $109.3M 5.1% | $47.7M 2.5% | $221K 0.0% | $849K 0.0% |
| Pretax Income | $223.8M 10.3% | $231.4M 12.2% | $242.6M 13.2% | $224.9M 13.0% |
| Income Tax Expense | $51.0M 2.4% | $59.5M 3.1% | $57.9M 3.1% | $52.7M 3.1% |
| Net Income | $166.4M 7.7% | $166.5M 8.8% | $179.9M 9.8% | $166.7M 9.7% |
| Per Share | ||||
| EPS (Basic) | $1.30 | $1.46 | $1.73 | $1.60 |
| EPS (Diluted) | $1.30 | $1.46 | $1.73 | $1.60 |
| Weighted Avg Shares (Basic) | 126.6M | 114.1M | 104.0M | 103.8M |
| Weighted Avg Shares (Diluted) | 128.3M | 114.2M | 104.2M | 103.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
The spread has compressed 3 years running.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2022 | 20.0% | 8.2% (today's — no rate published for this year) | 11.9pts |
| FY2023 | 13.7% | 7.3% | 6.4pts |
| FY2024 | 11.1% | 8.3% | 2.8pts |
| FY2025 | 10.3% | 7.9% | 2.4pts |
| Now | 8.5% | 8.2% | 0.3pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2022 | not reported | 15.0% | 9.7% |
| FY2023 | not reported | 15.6% | 9.8% |
| FY2024 | not reported | 16.0% | 8.8% |
| FY2025 | not reported | 15.4% | 7.7% |
Leverage and buybacks account for 34 points of the 42% return on equity in FY2025. The business earns 8% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$1.5B of goodwill — 59% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer. With goodwill over half the base, the ex-goodwill figure divides by a small remainder and moves sharply — read it as a direction, not a precise rate.
ROIC ex-goodwill is 24.84% against 10.14% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
Converts 1.19x of reported profit into free cash flow over 4 years, with accruals negative.
Shares outstanding are up 24% since FY2022 — per-share cash flow has grown more slowly than the totals above, and the gap is the owners'.
Covers interest 2.1x under stress — adequate, without much room.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 3.06x |
| 5% | 2.90x |
| 10% | 2.75x |
| 15% | 2.60x |
| 20% | 2.44x |
| 25% | 2.29x |
| 30% | 2.14x |
| 35% | 1.99x |
| 40% | 1.83x |
| 45% | 1.68x |
| 50% | 1.53x |
| 55% | 1.38x |
| 60% | 1.22x |
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
Net debt is 5.3x EBITDA, so coverage today depends on earnings holding up rather than on the balance sheet.
At $37.46, free cash flow must compound 11.12%/yr for 10 years. It has done -4.79%/yr over 3 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2023 | −25.8% | 11.1% |
| FY2024 | 24.2% | 11.1% |
| FY2025 | −6.3% | 11.1% |
The implied rate has been matched or beaten in 1 of the last 3 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $166M | $166M |
| Share-based comp | $10M | $177M |
| Other non-cash & working capital | $102M | $279M |
| Operating cash flow | $279M | $279M |
| Capex | −$82M | $197M |
| Free cash flow | $197M | $197M |
| FCF after SBC | $187M | $187M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2023 | 6.6% | not reported | not reported |
| FY2024 | 3.4% | 0.7% | -2.7 points |
| FY2025 | 13.8% | 18.5% | 4.6 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2022 | not reported | not reported | not reported | not reported |
| FY2023 | 42.9 days | not reported | not reported | not reported |
| FY2024 | 41.8 days | not reported | not reported | not reported |
| FY2025 | 43.5 days | not reported | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2022 | -4.7 percent |
| FY2023 | -2.3 percent |
| FY2024 | -4.3 percent |
| FY2025 | -4.0 percent |
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position